NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

Your AI produced nonsense. Please try again.

No one expects a separate line item for Expenses related to Specials. Those Expenses are treated as part of R&D, with minimal detail.

We do know that for the last year, R&D expense increased by $7.2 million (27.7 to 34.9), and that $0.8 million of that increase was related to Specials.

"$0.8 million for manufacturing cost increases in the Specials-Compassionate Treatment program, and "

The line above is a real 10-K quote, cut and pasted directly, not an AI-fabricated quote. Try that sometime.